 The purpose of this study is to evaluate the pharmacokinetics study of what the body does to a drug and safety of paliperidone palmitate ranging from 75 to 150 milligram equivalents in repeated doses 4 injections administered in the deltoid muscle muscle in the shoulder or gluteal muscle group of muscles present in the buttocks in participants with schizophrenia. 